BsUFA III negotiations turn to supplements, technology proposals

Regulatory News

Regulatory NewsJoanne S. Eglovitch

Biologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaProduct LifecycleRegulatory Intelligence/Policy